MAST3 was found to be a factor in inflammatory bowel disease (IBD) tissues to increase Toll-like receptor (TLR) 4-dependent NF-κB activity and knock-down of MAST3 resulted in reduced NF-κB activity [40]. This evidence concerns the gene NFKB1 and inflammatory bowel disease.